- Home
- BLZE vs RCKT Comparison
BLZE vs RCKT Comparison
Compare BLZE & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLZE
- RCKT
- Stock Information
- Founded
- BLZE 2007
- RCKT 1999
- Country
- BLZE United States
- RCKT United States
- Employees
- BLZE N/A
- RCKT N/A
- Industry
- BLZE Computer Software: Prepackaged Software
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- BLZE Technology
- RCKT Health Care
- Exchange
- BLZE Nasdaq
- RCKT Nasdaq
- Market Cap
- BLZE 326.5M
- RCKT 326.4M
- IPO Year
- BLZE 2021
- RCKT N/A
- Fundamental
- Price
- BLZE $5.36
- RCKT $2.59
- Analyst Decision
- BLZE Strong Buy
- RCKT Buy
- Analyst Count
- BLZE 7
- RCKT 13
- Target Price
- BLZE $10.29
- RCKT $18.50
- AVG Volume (30 Days)
- BLZE 386.9K
- RCKT 4.5M
- Earning Date
- BLZE 08-07-2025
- RCKT 08-04-2025
- Dividend Yield
- BLZE N/A
- RCKT N/A
- EPS Growth
- BLZE N/A
- RCKT N/A
- EPS
- BLZE N/A
- RCKT N/A
- Revenue
- BLZE $132,273,000.00
- RCKT N/A
- Revenue This Year
- BLZE $16.08
- RCKT N/A
- Revenue Next Year
- BLZE $13.97
- RCKT N/A
- P/E Ratio
- BLZE N/A
- RCKT N/A
- Revenue Growth
- BLZE 21.81
- RCKT N/A
- 52 Week Low
- BLZE $3.94
- RCKT $2.19
- 52 Week High
- BLZE $8.08
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- BLZE 49.98
- RCKT 31.97
- Support Level
- BLZE $5.29
- RCKT $2.56
- Resistance Level
- BLZE $5.60
- RCKT $2.70
- Average True Range (ATR)
- BLZE 0.22
- RCKT 0.20
- MACD
- BLZE 0.00
- RCKT 0.10
- Stochastic Oscillator
- BLZE 59.82
- RCKT 10.22
About BLZE Backblaze Inc.
Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.